Modular design of Salmonella Typhimurium OMV-based nanovaccines for tunable dual-form polysaccharide antigen delivery
PLOS Pathogens · 04.11.2026 · 22 (11) · e1014781
DOI: 10.1371/journal.ppat.1014781 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 04.11.2026. Verfasst von Mengru Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Southwest University, Beibei, Chongqing, China. Hauptthemen laut MEDLINE: Salmonella typhimurium, O Antigens, Polysaccharides, Bacterial, Bacterial Vaccines. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China, National Outstanding Youth Science Fund Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
Bacterial diseases are primarily managed with antibiotics, but vaccination is widely acknowledged as the most efficacious strategy for their prevention. Bacterial polysaccharides serve as key protective antigens in hosts and are therefore consistently prioritized as targets for bacterial vaccine development. Polysaccharide-conjugated vaccines have emerged as a promising and effective approach to combat multidrug-resistant bacteria. In order to construct a vaccine carrier capable of delivering bacterial polysaccharides while inducing robust immune response, this study utilized outer membrane vesicles (OMVs) derived from Salmonella Typhimurium as the vaccine carrier instead of the traditional adjuvant components to enhance the immunogenicity of polysaccharide vaccine. S. Typhimurium was genetically engineered to enable the controlled synthesis of LPS and glycoprotein, which were encapsulated within OMVs as two distinct polysaccharide vaccine formulations. This engineered delivery system was used to deliver the O-antigen polysaccharide of Shigella flexneri 3a, and subsequent validation in a murine model further confirmed that its ability to elicit an effective in vivo immune response. The polysaccharide delivery carrier platform established in this study provides a foundation for the subsequent multi-form delivery of bacterial polysaccharides in next-generation biological vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Southwest University, Beibei, Chongqing, China.
- College of Veterinary Medicine, Shandong Agricultural University, Taian, Shandong, China.
ORCID-Profile: Qingke Kong
Förderung
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Li, M., Zhou, K., Lei, M., Cao, H., Liu, X., Li, S., Wu, R., Yang, M., Bian, X., Cao, L., & Kong, Q. (2026). Modular design of Salmonella Typhimurium OMV-based nanovaccines for tunable dual-form polysaccharide antigen delivery. PLOS Pathogens, 22(11), e1014781. https://doi.org/10.1371/journal.ppat.1014781
Vancouver
Li M, Zhou K, Lei M, Cao H, Liu X, Li S, et al. Modular design of Salmonella Typhimurium OMV-based nanovaccines for tunable dual-form polysaccharide antigen delivery. PLOS Pathogens. 2026;22(11):e1014781. doi:10.1371/journal.ppat.1014781
BibTeX
@article{Li2026,
author = {Li, Mengru and Zhou, Kai and Lei, Meihong and Cao, Huanhuan and Liu, Xinyu and Li, Shan and Wu, Ruida and Yang, Ming and Bian, Xiaoping and Cao, Longlong and Kong, Qingke},
title = {Modular design of Salmonella Typhimurium OMV-based nanovaccines for tunable dual-form polysaccharide antigen delivery},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {11},
pages = {e1014781},
doi = {10.1371/journal.ppat.1014781}
}
EUVIMED